Heparan sulfate proteoglycans

Series edited by Renato V. Iozzo

Heparan sulfate proteoglycans are complex molecules consisting of a protein core and glycosaminoglycan side chains. Articles in the series summarize the current knowledge of heparan sulfate proteoglycan biology in various areas of basic biology and clinical medicine.

Published July 2001

Prostaglandins and their precursors

Series edited by Patrick Loll and Garret A. Fitzgerald

The cyclooxygenases COX-1 and COX-2 catalyze the conversion of arachidonic acid to biologically active prostaglandins, which have numerous physiological functions. The series discusses the current status and future promise of prostaglandin research.

Published June 2001

Matricellular proteins

Series edited by E. Helene Sage

This series on cell-matrix interactions discusses different molecules that mediate cell shape in vivo and in vitro, with a focus on the interpretation of extracellular signals at the cell surface.

Published April 2001

Bacterial polymorphisms

Series edited by Martin J Blaser and James M. Musser

The series introduces some of the biologically and medically relevant polymorphisms found in several species of bacteria, the basis for the genetic diversity in those populations, and its effect on human hosts.

Published February 2001

NF-kappaB in defense and disease

Series edited by Albert S. Baldwin

NF-kappaB is a primary effector of human disease. The series highlights the evolutionary conservation of the NF-kappaB pathway and its regulation as well as the diverse functions the transcription factor has in human health and disease.

Published January 2001

On diabetes: insulin resistance

Series edited by Alan R. Saltiel

Type 2 diabetes is a progressive disease that starts with peripheral insulin resistance, which in itself is a key feature of other human disease states. The series outlines the complex pathophysiology of insulin resistance, including the connections to obesity and cardiovascular disease.

Published January 2000

Nucleic acid therapeutics

Series edited by Bruce Sullenger

The series provides an update on progress in the field of nucleic acid-based therapeutics. Individual articles explore a number of strategies that exploit different facets of DNA and RNA biochemistry towards the development of safe and effective therapeutics.

Published January 2000

Stem cell biology

Series edited by Pamela Robey

The series reviews the broad array of stem cell types and stimulate discussion of the controversies and challenges that face the field. The articles suggest that a new conceptual framework is needed for thinking about stem cells and their therapeutic potential.

Published January 2000

Epigenetic regulation

Series edited by Benjamin Tycko

Epigenetic effects are changes in the genetic material that alter gene expression in a manner that is heritable during somatic cell divisions but nonmutational and therefore fundamentally reversible. The articles consider the consequences of epigenetic changes for human disease phenotypes.

Published January 2000

Cancer biotherapy

Series edited by David Kirn

The series reviews the emerging field of tumor-targeted microbes, which offer great potential for antitumoral potency and selective targeting of cancer cells and act by mechanisms not subject to cross-resistance when combined with standard therapies.

Published January 2000